Related Experiment Video
Updated: Aug 9, 2025

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Contemporary Outcomes of Tracheostomy in Patients With Single Ventricle Heart Lesions
Dominic Zanaboni1, Sunkyung Yu1, Ray Lowery1
1Division of Pediatric Cardiology, 1259University of Michigan C.S. Mott Children's Hospital, Ann Arbor, MI, USA.
Insights
Tracheostomy in single ventricle heart disease patients is linked to survival rates that depend on the reason for the procedure. Upper airway issues may offer better outcomes than respiratory insufficiency.
Area of Science:
- Pediatric Cardiology
- Thoracic Surgery
- Critical Care Medicine
Background:
- Tracheostomy is required in 0.2%–2.7% of children with congenital heart disease post-surgery.
- Single ventricle (SV) heart lesions are the most common reason for tracheostomy in these patients.
- Tracheostomy in SV patients is associated with significant mortality risks.
Purpose of the Study:
- To investigate the association between tracheostomy indications and survival rates in patients with single ventricle heart disease.
- To determine if specific reasons for tracheostomy impact short- and long-term survival.
- To evaluate the feasibility of completing staged palliation to Fontan circulation after tracheostomy.
Main Methods:
- A 20-year retrospective review was conducted at a single center.
- Data collected included demographics, cardiac anatomy, surgical details, and intensive care unit/hospital course.
- Survival following tracheostomy and completion of Fontan palliation were the primary and secondary outcomes, respectively.
Main Results:
- Twenty-five patients with SV heart disease underwent tracheostomy.
- Indications included tracheobronchomalacia, vocal cord paralysis, tracheal stenosis, respiratory insufficiency, diaphragm paralysis, and suboptimal hemodynamics.
- Overall survival rates at 6 months, 1, 5, and 10 years were 76%, 68%, 63%, and 49%, respectively. Patients with suboptimal hemodynamics/respiratory insufficiency had higher mortality (HR 4.1).
Conclusions:
- Mortality risk following tracheostomy in single ventricle heart disease patients is significantly influenced by the indication.
- Tracheostomy may facilitate staged surgical palliation for SV patients when indicated for airway dysfunction.
- Careful consideration of tracheostomy indication is crucial for optimizing outcomes in SV patients.
Objectives:
Approximately 0.2% to 2.7% of children with congenital heart disease require a tracheostomy after cardiac surgery with the majority having single ventricle (SV) type heart lesions. Tracheostomy in SV patients is reported to be associated with high mortality. We hypothesized that short- and long-term survival of patients with SV heart disease would vary according to tracheostomy indication.
Methods:
This is a single center, 20-year, retrospective review of all patients with SV heart disease who underwent tracheostomy. Demographic, cardiac anatomy, surgical, intensive care unit, and hospital course data were collected. The primary outcome was survival following tracheostomy. Secondary outcome was the completion of staged palliation to Fontan.
Results:
In total, 25 patients with SV heart disease who underwent tracheostomy were included. Indications for tracheostomy included one or more of the following: tracheobronchomalacia (n = 8), vocal cord paralysis (n = 7), tracheal/subglottic stenosis (n = 6), primary respiratory insufficiency (n = 4), diaphragm paralysis (n = 3), suboptimal hemodynamics (n = 2), and other upper airway issues (n = 1). Survival at six months, one year, five years, and ten years was 76%, 68%, 63%, and 49%, respectively. Most patients completed Fontan palliation (64%). Patients who underwent tracheostomy for suboptimal hemodynamics and/or respiratory insufficiency had a higher mortality risk compared to those with indications of upper airway obstruction or diaphragm paralysis (hazard ratio 4.1, 95% confidence interval 1.2-13.7; P = .02).
Conclusions:
Mortality risk varies according to tracheostomy indication in patients with SV heart disease. Tracheostomy may allow staged surgical palliation to proceed with acceptable risk if it was indicated for anatomic or functional airway dysfunction.
More Related Videos
Related Concept Videos
Tracheostomy: Procedure and Tubes
Tracheostomy tubes can be made of semiflexible plastic (polyurethane or silicone), rigid plastic, or metal, and they come in...
Tracheostomy Decannulation
Description of the Procedure
Decannulation refers to the permanent removal of the tracheostomy tube, signaling the resolution of the condition that initially necessitated the tracheostomy. The process requires a well-coordinated interplay between...
Tracheostomy Care II: Procedure
Step 1: Perform hand hygiene, and put on personal protective equipment: gown, gloves, mask...
Trachea
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of...
Oxygen Delivering System III: Tracheostomy and T-piece
Tracheostomy
A tracheostomy is a surgically created opening (stoma) in the anterior part of the trachea. It is used to establish a patient airway, bypass an upper airway obstruction, simplify the removal of secretions, permit long-term...
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...

